OVIT (OncoVista Innovative Therapies) Change In Receivables: $0.00 Mil (TTM As of Sep. 2015)


What is OncoVista Innovative Therapies Change In Receivables?

OncoVista Innovative Therapies OVIT Change In Receivables is $0.00 Mil as of Sep. 2015.

OncoVista Innovative Therapies's change in receivables for the quarter that ended in Sep. 2015 was $0.00 Mil. It means OncoVista Innovative Therapies's Accounts Receivable stayed the same from Jun. 2015 to Sep. 2015 .

OncoVista Innovative Therapies's change in receivables for the fiscal year that ended in Dec. 2014 was $0.05 Mil. It means OncoVista Innovative Therapies's Accounts Receivable declined by $0.05 Mil from Dec. 2013 to Dec. 2014 .

OncoVista Innovative Therapies's Accounts Receivable for the quarter that ended in Sep. 2015 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. OncoVista Innovative Therapies's liquidation value for the three months ended in Sep. 2015 was $-6.59 Mil.

OncoVista Innovative Therapies  (OTCPK:OVIT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

OncoVista Innovative Therapies's Days Sales Outstanding for the quarter that ended in Sep. 2015 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, OncoVista Innovative Therapies's accounts receivable are only considered to be worth 75% of book value:

OncoVista Innovative Therapies's liquidation value for the quarter that ended in Sep. 2015 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.061-6.651+0.75 * 0+0.5 * 0
=-6.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Change In Receivables Related Terms

OncoVista Innovative Therapies Change In Receivables Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Change In Receivables Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.01 -0.01 0.01 0.05

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Change In Receivables of $0.00 Mil as of Sep. 2015. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Change In Receivables too high?
OncoVista Innovative Therapies' current Change In Receivables is $0.00 Mil.
How does OncoVista Innovative Therapies' Change In Receivables compare to RSPI and HSTC?
OncoVista Innovative Therapies' Change In Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Change In Receivables is $0.00 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.